Free Trial

4D pharma (LBPSW) Competitors

LBPSW vs. ATNFW, AEHAW, AIMDW, ALVOW, ARAV, ACABW, BFRIW, BTMDW, BCTXW, and CALA

Should you be buying 4D pharma stock or one of its competitors? The main competitors of 4D pharma include 180 Life Sciences (ATNFW), Aesther Healthcare Acquisition (AEHAW), Ainos (AIMDW), Alvotech (ALVOW), ARAVIVE (ARAV), Atlantic Coastal Acquisition Corp. II (ACABW), Biofrontera (BFRIW), biote (BTMDW), BriaCell Therapeutics (BCTXW), and Calithera Biosciences (CALA). These companies are all part of the "pharmaceutical products" industry.

4D pharma vs. Its Competitors

4D pharma (NASDAQ:LBPSW) and 180 Life Sciences (NASDAQ:ATNFW) are both pharmaceutical products companies, but which is the better investment? We will compare the two businesses based on the strength of their analyst recommendations, earnings, risk, dividends, media sentiment, profitability, institutional ownership and valuation.

Company Net Margins Return on Equity Return on Assets
4D pharmaN/A N/A N/A
180 Life Sciences N/A N/A N/A

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
4D pharma$522KN/AN/AN/AN/A
180 Life SciencesN/AN/AN/AN/AN/A

In the previous week, 180 Life Sciences had 1 more articles in the media than 4D pharma. MarketBeat recorded 1 mentions for 180 Life Sciences and 0 mentions for 4D pharma. 180 Life Sciences' average media sentiment score of 1.89 beat 4D pharma's score of 0.00 indicating that 180 Life Sciences is being referred to more favorably in the news media.

Company Overall Sentiment
4D pharma Neutral
180 Life Sciences Very Positive

Summary

180 Life Sciences beats 4D pharma on 2 of the 3 factors compared between the two stocks.

Get 4D pharma News Delivered to You Automatically

Sign up to receive the latest news and ratings for LBPSW and its competitors with MarketBeat's FREE daily newsletter.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

LBPSW vs. The Competition

Metric4D pharmaPharmaceutical Preparation Manufacturing IndustryManufacturing SectorNASDAQ Exchange
Market CapN/AN/A$2.18B$9.52B
Dividend YieldN/AN/A2.57%3.99%
P/E RatioN/AN/A22.1420.02
Price / SalesN/AN/A91.03104.32
Price / CashN/AN/A28.9258.97
Price / BookN/AN/A59.775.90
Net IncomeN/AN/A-$121.56M$258.50M

4D pharma Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
LBPSW
4D pharma
N/AN/AN/AN/A$0.00$522K0.00N/A
ATNFW
180 Life Sciences
N/A$0.01
+3.4%
N/A+11.8%$0.00N/A0.007Positive News
Gap Down
High Trading Volume
AEHAW
Aesther Healthcare Acquisition
N/A$0.00
flat
N/AN/A$0.00N/A0.002
AIMDW
Ainos
N/A$0.18
+5.9%
N/AN/A$0.00$106.21K0.0040Positive News
Gap Up
ALVOW
Alvotech
N/A$1.65
+7.1%
N/A-27.2%$0.00$585.60M0.004Positive News
Gap Up
ARAV
ARAVIVE
N/A$0.04
flat
N/AN/A$0.00$9.14M0.0020High Trading Volume
ACABW
Atlantic Coastal Acquisition Corp. II
N/A$0.04
+75.5%
N/AN/A$0.00N/A0.0015
BFRIW
Biofrontera
N/A$0.10
+2.9%
N/AN/A$0.00$38.00M0.0070Positive News
BTMDW
biote
N/A$0.01
-1.5%
N/A-97.2%$0.00$199.38M0.00N/AGap Up
BCTXW
BriaCell Therapeutics
N/A$0.05
+30.4%
N/A-65.8%$0.00N/A0.008Positive News
Gap Up
CALA
Calithera Biosciences
N/A$0.00
flat
N/A-99.5%$0.00N/A0.0060

Related Companies and Tools


This page (NASDAQ:LBPSW) was last updated on 7/25/2025 by MarketBeat.com Staff
From Our Partners